Recently, MYC was shown to be one of the key TFs for SCLC [32,63–65], which initiates Notch signaling to reprogram neuroendocrine fate from NE to NEv1 to NEv2 to NON-NE states [40]. This evidence concerns the gene MYC and small cell lung carcinoma.